SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52153 679 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52128Good morning. Several of my biotechs are leaping tall buildings in a single bounSun Tzu-12/2/2024
52127RFK making dividends great again. PFE 6.77% GSK 4.62% BMY 4.27% Others like AMGJamesK-11/16/2024
52126If there is a pattern in what often becomes a major fall in market value of a stArt Bechhoefer111/10/2024
52125Wasn't meant to be comprehensive. I didn't screen names. Was off the topJamesK-11/9/2024
52124CRVS should be on your list.Aloner-11/8/2024
52123ALNY ARGX RVMD AMGN VRTX REGN VKTX Just posting a few names that have exceeded tJamesK311/8/2024
52122nature.com the effects of GLP-1 agonists across the economy. one nugget: Andsoftware salesperson211/5/2024
52121KZIA is up 348% on the week. A small Biotech that announced positive Phase II clAloner-7/13/2024
52120Good results from a Phase 3 trial of Vutrisaran, an RNAi therapy against ATTR caA.J. Mullen-6/24/2024
52119Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s Peoplesoftware salesperson45/7/2024
52118erictopol.substack.com A Big Week for GLP-1 Drugs A Breakthrough Award, Nesoftware salesperson15/3/2024
52117Sorry don't follow them but they have a $5 billion plus market cap so they mJamesK-5/1/2024
52116IBRX anyone? Any holders, buyers, sellers, opinions, suggestions, complaints or Aloner-4/26/2024
52115Yes. Compare VINC to the great VKTX offering. The xbi run up over 100 has allowJamesK-4/26/2024
52114That's how it always goes with biotechs. If they can't license the drug,Sun Tzu-4/25/2024
52113VINC - sorry I ever mentioned this one. After declining all the way back down thJamesK-4/25/2024
52112Wow! Amazing!Sun Tzu-3/29/2024
52111VINC was .61 at bottom in the bio bear. Now over 9. There's a lot of these lJamesK-3/11/2024
52110VKTX - up on take over rumor. Seems unlikely before we see data on their drugs. JamesK-2/16/2024
52109ARGUS Opinion: Since 2021, the biotechnology industry has underperformed the broAloner11/24/2024
52108additional reasons over and above fewer side effects that novavax is better thansoftware salesperson21/21/2024
52107Does anyone know of a market cap weighted broad biotech ETF? I am looking for soSun Tzu-1/5/2024
521062024 Biotech Charity Contest Up & Running! Come one, come all, pick your btechnetium-12/29/2023
52105nytimes.com Serious Medical Errors Rose After Private Equity Firms Bought Hospisoftware salesperson212/27/2023
52104eric topol's latest substack on covid, nasal vaccines, long covid and, unforsoftware salesperson112/17/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News